ID |
ET-075 |
Formula |
C12H15NO4 |
CAS |
69907-67-1 |
MW |
237.3 |
Purity |
>99% |
Storage |
+2 ... +8 °C |
References
Mal-AMCHC is used as a linker in various applications. It is employed as an antibody-drug linker in approved cancer medication Kadcyla by Genentech/Roche and used as a linker in PCA-062 by Novartis, currently in clinical trials. It is also used in IMMU-132 by Immunomedics, currently in clinical trials.
BACK TO PRODUCT LIST
